Abstract
Human coronaviruses are pathogenic viruses that have the ability to cause serious diseases or even death in humans. The receptor binding domain (RBD) of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is the region of the spike protein, through which the virus directly interacts with the human Angiotensin-converting enzyme 2 receptor (ACE-2). Understanding the mutations that occur in the RBD and determining their influence on host cell binding plays an essential role in learning about the transmission mechanism of the disease and developing potential treatment. We chose to apply the error-prone Polymerase Chain Reaction (ep-PCR), usually used in directed evolution and targeted mutagenesis applications, and to optimize it for the SARS-CoV-2 RBD sequence. This was followed by sequencing to analyze the mutation pattern. In this study, a novel ep-PCR protocol was developed specifically for RBD, optimized for dNTP ratios, magnesium ions, manganese ions, and cycle numbers. Our results highlight the virulence-enhancing potential of mutations and enable researchers to evaluate potential vaccine candidates in the future. Furthermore, compared to earlier reports, the method described here requires only Sanger sequencing and a standard PCR cycler, therefore it is much more accessible. Most importantly, it yields combinatorial mutation diversity in one round, along the entire length of the sequence of interest.
Keywords
MeSH Terms
Affiliated Institutions
Related Publications
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
Antibodies targeting the SARS-CoV-2 spike receptor-binding domain (RBD) are being developed as therapeutics and are a major contributor to neutralizing antibody responses elicit...
Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding
The receptor binding domain (RBD) of the SARS-CoV-2 spike glycoprotein mediates viral attachment to ACE2 receptor and is a major determinant of host range and a dominant target ...
Recombination and lineage-specific mutations linked to the emergence of SARS-CoV-2
Abstract The emergence of SARS-CoV-2 underscores the need to better understand the evolutionary processes that drive the emergence and adaptation of zoonotic viruses in humans. ...
Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
Abstract The outbreak of Coronavirus Disease 2019 (COVID-19) has posed a serious threat to global public health, calling for the development of safe and effective prophylactics ...
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2
Hitting SARS-CoV-2 in a new spot A key target for therapeutic antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the spike protein, a trimeric pr...
Publication Info
- Year
- 2025
- Type
- article
- Volume
- 53
- Issue
- 1
- Pages
- 184-184
- Citations
- 0
- Access
- Closed
External Links
Social Impact
Social media, news, blog, policy document mentions
Citation Metrics
Cite This
Identifiers
- DOI
- 10.1007/s11033-025-11359-5
- PMID
- 41369845